Authors:
BAROSI G
AMBROSETTI A
CENTRA A
FALCONE A
FINELLI C
FOA P
GROSSI A
GUARNONE R
RUPOLI S
LUCIANO L
PETTI MC
POGLIANI E
RUSSO D
RUGGERI M
QUAGLINI S
Citation: G. Barosi et al., SPLENECTOMY AND RISK OF BLAST-TRANSFORMATION IN MYELOFIBROSIS WITH MYELOID METAPLASIA, Blood, 91(10), 1998, pp. 3630-3636
Authors:
DICOSTANZO F
GASPERONI S
ROSSETTI R
OLMEO N
ZIRONI S
GILLI G
ROCCA A
ROVEJ R
LEONARDI F
BRUNO L
CATALANO G
FOA P
PARRINELLO GA
CAVICCHI F
ANTIMI M
ANGIONA S
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY IN COMPLETE RESECTED GASTRIC-CANCER - EVALUATION IN DOUBLE-LEFT-ARROW-60 VS GREATER-THAN-60 YEARS PTS, Annals of oncology, 9, 1998, pp. 65-65
Authors:
FOA P
MASSARO P
CALDIERA S
LATARGIA ML
IURLO A
CLERICI C
FORNIER M
BERTONI F
MAIOLO AT
Citation: P. Foa et al., LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA, European journal of haematology, 60(5), 1998, pp. 273-277
Authors:
FOA P
MASSARO P
CALDIERA S
LATARGIA M
IURLO A
FORNIER M
BERTONI F
MAIOLO AT
Citation: P. Foa et al., LONG-TERM THERAPEUTIC EFFICACY AND TOXICITY OF RECOMBINANT INTERFERON-ALPHA 2A IN POLYCYTHEMIA-VERA, European journal of cancer, 33, 1997, pp. 381-381
Authors:
MASSARO P
FOA P
POMATI M
LATARGIA ML
IURLO A
CLERICI C
CALDIERA S
FORNIER M
MAIOLO AT
Citation: P. Massaro et al., POLYCYTHEMIA-VERA TREATED WITH RECOMBINANT INTERFERON-ALPHA 2A - EVIDENCE OF A SELECTIVE EFFECT ON THE MALIGNANT CLONE, American journal of hematology, 56(2), 1997, pp. 126-128
Authors:
IURLO A
FORNIER M
CALDIERA S
BERTONI F
FOA P
Citation: A. Iurlo et al., PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME DUE TO 5-FLUOROURACIL THERAPY - AN UNDERESTIMATED TOXIC EVENT, Acta oncologica, 36(6), 1997, pp. 653-654
Authors:
FOA P
IURLO A
ORAZI A
SAGLIO G
RIBERA S
BERTONI F
CALDIERA S
FORNIER M
MAIOLO AT
Citation: P. Foa et al., BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY, Acta haematologica, 97(3), 1997, pp. 187-188
Authors:
FOA P
IURLO A
RIBERA S
DAMILANO I
CALDIERA S
FORNIER M
BERTONI F
MAIOLO AT
Citation: P. Foa et al., CHRONIC MYELOID-LEUKEMIA TREATED WITH BUSULFAN - RELATIONSHIP BETWEENTOTAL AMOUNT OF DRUG REQUIRED DURING THE FIRST YEAR OF TREATMENT AND DURATION OF CHRONIC PHASE, Oncology Reports, 3(6), 1996, pp. 1067-1069
Authors:
FOA P
POMATI M
RIBERA S
CALDIERA S
BERTONI F
FORNIER M
MAIOLO AT
Citation: P. Foa et al., FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) FOR EVALUATING RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA DURING INTERFERON-ALPHA THERAPY, Oncology Reports, 3(5), 1996, pp. 847-849
Authors:
SEREGNI E
FOA P
BOGNI A
BOTTI C
CATALDO I
SALA M
MEZZETTI M
GASPARINI M
SANTAMBROGIO L
LEGNANI D
BOMBARDIERI E
Citation: E. Seregni et al., EVALUATION OF THE SOLUBLE FRAGMENTS OF CYTOKERATIN-19 (CK19) IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - COMPARISON WITH TPA, CEA, SCC AND NSE, Oncology Reports, 3(1), 1996, pp. 95-101
Authors:
FOA P
SEREGNI E
SANTAMBROGIO L
MEZZETTI M
SALA M
IURLO A
BOMBARDIERI E
Citation: P. Foa et al., CYTOKERATIN-19 SOLUBLE FRAGMENTS (CK19) DETERMINATION IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER (NSCLC) - COMPARISON WITH TPA, CEA, SCC AND NSE, European journal of cancer, 31A, 1995, pp. 1264-1264
Citation: M. Arquati et al., AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH IDIOPATHIC HYPEREOSINOPHILIA, American journal of hematology, 49(4), 1995, pp. 356-356
Authors:
MONTAGNA C
MASSARO P
MORALI F
FOA P
MAIOLO AT
ERIDANI S
Citation: C. Montagna et al., IN-VITRO SENSITIVITY OF HUMAN ERYTHROID PROGENITORS TO HEMATOPOIETIC GROWTH-FACTORS - STUDIES ON PRIMARY AND SECONDARY POLYCYTHEMIA, Haematologica, 79(4), 1994, pp. 311-318
Citation: P. Foa et al., RENAL-CANCER AFTER BUSULFAN TREATMENT FOR CHRONIC MYELOID-LEUKEMIA - THERAPEUTIC IMPLICATIONS, Annals of oncology, 4(6), 1993, pp. 521-522
Authors:
TURA S
FANIN R
RUSSO D
ZUFFA F
FIACCHINI M
BACCARANI M
TESTONI N
ZAMAGNI D
ZACCARIA A
DAMIANI D
MICHIELI M
ALIMENA G
MONTEFUSCO E
MANDELLI F
MORRA E
BERNASCONI C
GUGLIELMI P
CACCIOLA E
BATTISTA R
DINI E
SPECCHIA G
LISO V
MAJOLINO I
CARONIA F
LEONI P
DANIELI G
NOSARI A
DECATALDO F
PAOLINO F
RESEGOTTI L
COMOTTI B
BARBUI T
SCAPOLI GL
CASTOLDI GL
PROSSOMARITI L
MONTUORI R
RICCARDI A
ASCARI E
LANDOLFI R
BIZZI B
LOMBARDO M
TORLONTANO G
LEONI F
FERRINI PR
SPARAVENTI G
DELFINI C
PAPINESCHI F
SPREMOLLA G
BROCCIA G
NARDELLI S
CICCONE F
DERIU L
MIRAGLIA E
DEBIASE R
BODENIZZA CA
CAROTENUTO M
ROTONDO SG
GENTILINI I
COSER P
CAPUCCI A
IZZI T
LUCIANO L
ROTOLI B
IACOPINO P
NOBILE F
CANTONETTI M
PAPA G
PINOTTI G
SALA G
FOA P
MAIOLO MT
AVANZINI P
GOBBI F
DORE F
PARDINI S
AMBROSETTI A
PERONA G
DINI D
LIBERATI AM
MARTELLI M
GRIGNANI F
MONTUORO A
DELAURENZI A
GALLO E
PILERI A
GALLAMINI A
BUFFA F
ABBADESSA A
BRUZZESE L
DEROSA C
CIMINO R
MANGONI L
RIZZOLI V
PIZZUTI M
RICCIUTI F
GALIENI P
DISPENSA E
ZAGONEL V
PINTO A
MUSOLINO C
SQUADRITO G
PERRICONE R
CAJOZZO A
MORANDI S
BIANCHINI E
MILIANI A
MONACO M
DIFRANCESCO A
QUAGLINO D
ROSTI G
MARANGOLO M
PASINI FL
DIPERRI T
AGLIETTA M
GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299